Found: 95
Select item for more details and to access through your institution.
Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 983, doi. 10.1093/cid/ciae183
- By:
- Publication type:
- Article
Acceptable Plasma Concentrations of Raltegravir and Etravirine When Administered by Gastrostomy Tube in a Patient with Advanced Multidrug-Resistant Human Immunodeficiency Virus Infection.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 2, p. 142, doi. 10.1002/PHAR.1015
- By:
- Publication type:
- Article
Decreased MEG beta oscillations in HIV-infected older adults during the resting state.
- Published in:
- Journal of NeuroVirology, 2013, v. 19, n. 6, p. 586, doi. 10.1007/s13365-013-0220-8
- By:
- Publication type:
- Article
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection.
- Published in:
- Annals of Internal Medicine, 2000, v. 133, n. 1, p. 21, doi. 10.7326/0003-4819-133-1-200007040-00004
- By:
- Publication type:
- Article
Pharmacokinetics of Hydroxyurea in Plasma and Cerebrospinal Fluid of HIV-1-Infected Patients.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 9, p. 1003
- By:
- Publication type:
- Article
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.
- Published in:
- Current HIV/AIDS Reports, 2020, v. 17, n. 6, p. 589, doi. 10.1007/s11904-020-00529-8
- By:
- Publication type:
- Article
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low Prevalence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Colonization and Apparent Lack of Correlation with Sexual Behavior among HIV-Infected Patients in Nebraska.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Potential Risks and Benefits of HIV Treatment Simplification: A Simulation Model of a Proposed Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2007, v. 45, n. 8, p. 1062, doi. 10.1086/521933
- By:
- Publication type:
- Article
Plasma Levels of Soluble CD14 and Tumor Necrosis Factor-alpha Type II Receptor Correlate with Cognitive Dysfunction during Human Immunodeficiency Virus Type 1 Infection.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 6, p. 699, doi. 10.1086/323036
- By:
- Publication type:
- Article
Suppression of Inflammatory Neurotoxins by Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus—Associated Dementia.
- Published in:
- Journal of Infectious Diseases, 1998, v. 178, n. 4, p. 1000
- By:
- Publication type:
- Article
The Critical Need for Alternative Antiretroviral Formulations, and Obstacles to Their Development.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 5, p. 669
- By:
- Publication type:
- Article
Increased Plasma Human Immunodeficiency Virus Type 1 Burden following Antigenic Challenge with Pneumococcal Vaccine.
- Published in:
- Journal of Infectious Diseases, 1996, v. 174, n. 6, p. 1191, doi. 10.1093/infdis/174.6.1191
- By:
- Publication type:
- Article
Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2023, v. 109, n. 4, p. 752, doi. 10.4269/ajtmh.23-0245
- By:
- Publication type:
- Article
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 343, doi. 10.1164/rccm.202311-2004OC
- By:
- Publication type:
- Article
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Trials of Tuberculosis-Preventive Therapy in People with HIV Infection.
- Published in:
- 2020
- By:
- Publication type:
- letter
Reply to Decroo : High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
- Published in:
- 2020
- By:
- Publication type:
- letter
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Functional Brain Abnormalities During Finger-Tapping in HIV-Infected Older Adults: A Magnetoencephalography Study.
- Published in:
- Journal of NeuroImmune Pharmacology, 2013, v. 8, n. 4, p. 965, doi. 10.1007/s11481-013-9477-1
- By:
- Publication type:
- Article
The Effect of HIV Protease Inhibitors on Amyloid-β Peptide Degradation and Synthesis in Human Cells and Alzheimer's Disease Animal Model.
- Published in:
- Journal of NeuroImmune Pharmacology, 2012, v. 7, n. 2, p. 412, doi. 10.1007/s11481-011-9304-5
- By:
- Publication type:
- Article
Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1–Infected Human Peripheral Blood Lymphocyte–Reconstituted Mice.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 10, p. 1577, doi. 10.1093/infdis/jis395
- By:
- Publication type:
- Article
The critical need for alternative antiretroviral formulations, and obstacles to their development.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 6, p. 866, doi. 10.1086/597119
- By:
- Publication type:
- Article
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Race/Ethnicity on Survival among HIV-Infected Patients in Care.
- Published in:
- Journal of Health Care for the Poor & Underserved, 2009, v. 20, n. 4, p. 982, doi. 10.1353/hpu.0.0198
- By:
- Publication type:
- Article
Primary Care Physicians and the Cost of Drugs: A Study of Prescribing Practices Based on Recognition and Information Sources.
- Published in:
- 1994
- By:
- Publication type:
- Other
HIV-Associated Dementia: New Insights into Disease Pathogenesis and Therapeutic Interventions.
- Published in:
- AIDS Patient Care & STDs, 1999, v. 13, n. 3, p. 153, doi. 10.1089/apc.1999.13.153
- By:
- Publication type:
- Article
Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dolutegravir-induced colitis in an HIV-infected patient.
- Published in:
- 2016
- By:
- Publication type:
- case study
Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 262, doi. 10.1093/jac/dkt323
- By:
- Publication type:
- Article
Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 5, p. 221, doi. 10.1111/jvh.13921
- By:
- Publication type:
- Article
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1680, doi. 10.1093/cid/ciae119
- By:
- Publication type:
- Article
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 667, doi. 10.1093/cid/ciad583
- By:
- Publication type:
- Article
Zinc and Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 662, doi. 10.1093/cid/ciad229
- By:
- Publication type:
- Article
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1646, doi. 10.1093/cid/ciad020
- By:
- Publication type:
- Article
What Clinicians Need to Know About the Development of Long-Acting Formulations.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S487, doi. 10.1093/cid/ciac749
- By:
- Publication type:
- Article
Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S510, doi. 10.1093/cid/ciac672
- By:
- Publication type:
- Article
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 3, doi. 10.1093/cid/ciab913
- By:
- Publication type:
- Article
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 1037, doi. 10.1093/cid/ciab269
- By:
- Publication type:
- Article
Neighborhood Deprivation and Racial/Ethnic Disparities in Human Immunodeficiency Virus Viral Suppression: A Single-center, Cross-sectional Study in the United States Midwest.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. e642, doi. 10.1093/cid/ciaa1254
- By:
- Publication type:
- Article
Evidence From a Multistate Cohort: Enrollment in Affordable Care Act Qualified Health Plans' Association With Viral Suppression.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 10, p. 2572, doi. 10.1093/cid/ciz1123
- By:
- Publication type:
- Article
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 698, doi. 10.1093/cid/ciz784
- By:
- Publication type:
- Article
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 3, p. 425, doi. 10.1093/cid/ciz235
- By:
- Publication type:
- Article
Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 8, p. 972, doi. 10.1164/rccm.201105-0827WS
- By:
- Publication type:
- Article
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.
- Published in:
- BMC Infectious Diseases, 2015, v. 15, n. 1, p. 125, doi. 10.1186/s12879-014-0735-5
- By:
- Publication type:
- Article
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.
- Published in:
- BMC Infectious Diseases, 2005, v. 5, n. 1, p. 23, doi. 10.1186/1471-2334-5-23
- By:
- Publication type:
- Article